{"id":1538,"date":"2021-03-08T15:29:22","date_gmt":"2021-03-08T14:29:22","guid":{"rendered":"https:\/\/www.fluxmedicare.fr\/?page_id=1538"},"modified":"2026-06-04T15:13:02","modified_gmt":"2026-06-04T13:13:02","slug":"pdt-behandlung","status":"publish","type":"page","link":"https:\/\/www.fluxmedicare.fr\/de\/pdt-behandlung\/","title":{"rendered":"PDT-Behandlung"},"content":{"rendered":"

[et_pb_section fb_built=“1″ _builder_version=“4.16″ _module_preset=“default“ background_image=“https:\/\/www.fluxmedicare.fr\/wp-content\/uploads\/2019\/10\/AdobeStock_249422618-web.jpg“ background_position=“bottom_center“ custom_padding=“80px|80px|25px|80px|false|false“ global_colors_info=“{}“][et_pb_row column_structure=“1_2,1_2″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“1_2″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.16″ _module_preset=“default“ header_font=“Patua One||||||||“ header_font_size=“50px“ header_font_size_tablet=“42px“ header_font_size_phone=“30px“ header_font_size_last_edited=“on|desktop“ global_colors_info=“{}“]<\/p>\n

T-PDT-Lichttherapie<\/h1>\n

[\/et_pb_text][et_pb_divider color=“#0C71C3″ divider_weight=“5px“ _builder_version=“4.16″ _module_preset=“default“ width=“40%“ custom_margin=“||10px||false|false“ global_colors_info=“{}“][\/et_pb_divider][et_pb_text _builder_version=“4.27.0″ _module_preset=“default“ text_font=“Patua One||||||||“ text_text_color=“#0A0002″ text_font_size=“24px“ text_line_height=“1.2em“ global_colors_info=“{}“]<\/p>\n

Bei dem System FLUXMEDICARE\u00ae V2<\/a> handelt es sich um ein von MDB Texinov\u00ae<\/a> hergestelltes Medizinger\u00e4t der Klasse IIa gem\u00e4\u00df Verordnung (EU) 2017\/745, dessen Komformit\u00e4tsbewertung durch das Britische Institut f\u00fcr Normung BSI erfolgt ist.
Die Zubeh\u00f6rteile sind CE-gekennzeichnete
Medizinprodukte der Klasse I gem\u00e4\u00df der Verordnung\u00a0(EU) 2017\/745.<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=“1_2″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_image src=“https:\/\/www.fluxmedicare.fr\/wp-content\/uploads\/2021\/03\/DSC_3729_2.jpg“ title_text=“DSC_3729_2″ _builder_version=“4.16″ _module_preset=“default“ animation_style=“slide“ animation_direction=“right“ animation_intensity_slide=“10%“ box_shadow_style=“preset4″ box_shadow_horizontal=“40px“ box_shadow_vertical=“40px“ box_shadow_color=“#0C71C3″ global_colors_info=“{}“][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ _builder_version=“4.16″ _module_preset=“default“ custom_padding=“0px|||||“ global_colors_info=“{}“][et_pb_row column_structure=“1_2,1_2″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“1_2″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.16″ _module_preset=“default“ text_font_size=“16px“ header_4_font=“Patua One||||||||“ header_4_font_size=“24px“ custom_padding=“36px|36px|36px|36px|true|true“ border_width_all=“1px“ border_color_all=“#4AC3CD“ global_colors_info=“{}“]<\/p>\n

Klasse\/Notifizierungsstelle:<\/strong>\u00a0IIa \/ CE 2797
Hersteller:<\/strong>\u00a0MDB Texinov\u00ae<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=“1_2″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.16″ _module_preset=“default“ text_font=“Assistant||||||||“ text_font_size=“16px“ text_line_height=“1.6em“ global_colors_info=“{}“]<\/p>\n

Es ist f\u00fcr medizinische Fachkr\u00e4fte im Rahmen der Behandlung bestimmter dermatologischer Erkrankungen (aktinische Keratosen des Grads OLSEN 1 und 2) bestimmt.<\/strong><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=“4.16″ _module_preset=“default“ custom_padding=“||19px|||“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_image src=“https:\/\/www.fluxmedicare.fr\/wp-content\/uploads\/2026\/02\/Efficacite-sans-douleur-Phototherapie-Fluxmedicare.jpg“ title_text=“Efficacite-sans-douleur-Phototherapie-Fluxmedicare“ _builder_version=“4.27.0″ _module_preset=“default“ hover_enabled=“0″ global_colors_info=“{}“ sticky_enabled=“0″][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_2,1_2″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“1_2″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.16″ _module_preset=“default“ text_font=“Assistant||||||||“ text_text_color=“#0A0002″ text_font_size=“16px“ text_line_height=“1.3em“ global_colors_info=“{}“]Das FLUXMEDICARE\u00ae V2-Ger\u00e4t ist speziell f\u00fcr die Verwendung mit einer photosensibilisierenden Creme* entwickelt und optimiert<\/strong> die<\/strong> Gesamtbehandlungszeit bei der photodynamischen Therapie <\/strong>aktinischer Keratosen.<\/span><\/p>\n

<\/span><\/p>\n